Arvinas Inc (NASDAQ: ARVN) is -61.03% lower on its value in year-to-date trading and has touched a low of $5.90 and a high of $34.11 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The ARVN stock was last observed hovering at around $7.48 in the last trading session, with the day’s loss setting it -0.01%.
Currently trading at $7.47, the stock is 3.58% and 1.08% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 2.14 million and changing -0.13% at the moment leaves the stock -56.35% off its SMA200. ARVN registered -70.90% loss for a year compared to 6-month loss of -61.69%.
The stock witnessed a 14.40% gain in the last 1 month and extending the period to 3 months gives it a -14.14%, and is -2.61% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 1.60% over the week and 3.79% over the month.
Arvinas Inc (ARVN) has around 430 employees, a market worth around $545.25M and $161.00M in sales. Profit margin for the company is -92.98%. Distance from 52-week low is 26.61% and -78.10% from its 52-week high. The company has generated returns on investments over the last 12 months (-22.39%).
The EPS is expected to grow by 46.81% this year
The shares outstanding are 73.00M, and float is at 63.77M with Short Float at 12.12%.
The top institutional shareholder in the company is ECOR1 CAPITAL, LLC with over 6.73 million shares valued at $179.06 million. The investor’s holdings represent 9.3553 of the ARVN Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 6.67 million shares valued at $177.6 million to account for 9.2793 of the shares outstanding. The other top investors are BLACKROCK INC. which holds 6.26 million shares representing 8.7049 and valued at over $166.61 million, while PRICE T ROWE ASSOCIATES INC /MD/ holds 5.5478 of the shares totaling 3.99 million with a market value of $106.19 million.
Arvinas Inc (ARVN) Insider Activity
The most recent transaction is an insider sale by Cacace Angela M, the company’s Chief Scientific Officer. SEC filings show that Cacace Angela M sold 2,583 shares of the company’s common stock on Jun 17 ’25 at a price of $7.49 per share for a total of $19347.0. Following the sale, the insider now owns 0.15 million shares.
Arvinas Inc disclosed in a document filed with the SEC on Mar 18 ’25 that Berkowitz Noah (Chief Medical Officer) sold a total of 8,658 shares of the company’s common stock. The trade occurred on Mar 18 ’25 and was made at $8.59 per share for $74372.0. Following the transaction, the insider now directly holds 0.11 million shares of the ARVN stock.
Still, SEC filings show that on Mar 18 ’25, Noah Berkowitz (Officer) Proposed Sale 8,658 shares at an average price of $8.59 for $74372.0. The insider now directly holds shares of Arvinas Inc (ARVN).
